BOUT:NYE-Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF (USD)

ETF | Mid-Cap Growth |

Last Closing

USD 35.19

Change

+0.58 (+1.68)%

Market Cap

USD 0.01B

Volume

1.29K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-27 )

Largest Industry Peers for Mid-Cap Growth

Symbol Name Price(Change) Market Cap
IWP iShares Russell Mid-Cap Growth..

-0.11 (-0.08%)

USD 18.06B
VOT Vanguard Mid-Cap Growth Index ..

+0.07 (+0.03%)

USD 15.90B
IJK iShares S&P Mid-Cap 400 Growth..

+0.17 (+0.19%)

USD 8.83B
XMMO Invesco S&P MidCap Momentum ET..

+0.13 (+0.10%)

USD 3.81B
IVOG Vanguard S&P Mid-Cap 400 Growt..

+0.53 (+0.49%)

USD 1.08B
CWS AdvisorShares Focused Equity E..

+0.39 (+0.57%)

USD 0.18B
ETHO Amplify ETF Trust

+0.21 (+0.37%)

USD 0.18B
BFOR Barron's 400 ETF

+0.19 (+0.26%)

USD 0.15B
IPO Renaissance IPO ETF

-0.25 (-0.59%)

USD 0.14B
PEXL Pacer US Export Leaders ETF

+0.10 (+0.21%)

USD 0.04B

ETFs Containing BOUT

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Growth) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -9.93% 6% D- 19% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.93% 6% D- 18% F
Trailing 12 Months  
Capital Gain -0.62% 25% F 40% F
Dividend Return 0.02% 8% B- N/A F
Total Return -0.60% 19% F 31% F
Trailing 5 Years  
Capital Gain 64.02% 56% F 66% D+
Dividend Return 3.92% 44% F 8% B-
Total Return 67.94% 56% F 58% F
Average Annual (5 Year Horizon)  
Capital Gain 8.73% 72% C 68% D+
Dividend Return 9.34% 72% C 63% D
Total Return 0.61% 50% F 15% F
Risk Return Profile  
Volatility (Standard Deviation) 19.62% 61% D- 51% F
Risk Adjusted Return 47.59% 72% C 64% D
Market Capitalization 0.01B 8% B- 7% C-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.